Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets closed
S&P 500
5,254.35
+5.86
(+0.11%)
Dow 30
39,807.37
+47.29
(+0.12%)
Nasdaq
16,379.46
-20.06
(-0.12%)
Russell 2000
2,124.55
+10.20
(+0.48%)
Crude Oil
83.11
+1.76
(+2.16%)
Gold
2,254.80
+42.10
(+1.90%)
G1 Therapeutics Inc (G1H.BE)
Berlin - Berlin Delayed Price. Currency in EUR
Follow
4.0400
-0.0700
(-1.70%)
At close: 08:30PM CET
Summary
Company Insights
Chart
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Upgrade to begin using 40 years of financial statements and get so much more.
Download
Income Statement
Expand All
All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Learn more
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
77,888
82,511
51,301
31,476
45,285
Cost of Revenue
6,931
7,195
3,748
2,016
0
Gross Profit
70,957
75,316
47,553
29,460
45,285
Operating Expense
132,442
114,843
183,731
171,917
141,761
Operating Income
-61,485
-39,527
-136,178
-142,457
-96,476
Net Non Operating Interest Income Expense
-8,488
-7,565
-9,684
-4,624
-826
Other Income Expense
1,929
2,240
3
-346
-542
Pretax Income
-68,044
-44,852
-145,859
-147,427
-97,844
Tax Provision
2,694
3,115
1,700
925
1,410
Net Income Common Stockholders
-70,738
-47,967
-147,559
-148,352
-99,254
Diluted NI Available to Com Stockholders
-70,738
-47,967
-147,559
-148,352
-99,254
Basic EPS
-1.43
-
-3.38
-3.54
-2.62
Diluted EPS
-1.43
-
-3.38
-3.54
-2.62
Basic Average Shares
50,351
-
43,626
41,943
37,878
Diluted Average Shares
50,351
-
43,626
41,943
37,878
Total Operating Income as Reported
-61,485
-39,527
-136,178
-142,457
-96,476
Total Expenses
139,373
122,038
187,479
173,933
141,761
Net Income from Continuing & Discontinued Operation
-70,738
-47,967
-147,559
-148,352
-99,254
Normalized Income
-70,738
-47,967
-147,559
-148,352
-99,254
Interest Income
2,422
2,473
748
43
952
Interest Expense
10,910
10,038
10,432
4,667
1,778
Net Interest Income
-8,488
-7,565
-9,684
-4,624
-826
EBIT
-57,134
-34,814
-135,427
-142,760
-96,066
EBITDA
-56,608
-34,301
-134,897
-142,291
-95,484
Reconciled Cost of Revenue
6,931
7,195
3,748
2,016
0
Reconciled Depreciation
526
513
530
469
582
Net Income from Continuing Operation Net Minority Interest
-70,738
-47,967
-147,559
-148,352
-99,254
Normalized EBITDA
-56,608
-34,301
-134,897
-142,291
-95,484
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.